RATIONAL USE OF ANTIPYRETICS (PARACETAMOL AND IBUPROFEN) IN THE MANAGEMENT OF FEVER IN CHILDREN: AN EVIDENCE-BASED NARRATIVE REVIEW

DIGITAL OBJECT IDENTIFIER (DOI): https://doi.org/10.67620/sai.58d0009
Abdubannobova Dilnavoz1
1 Faculty of Pediatrics, Andijan State Medical Institute, Andijan, Uzbekistan
ReceivedAug 20, 2026
RevisedSep 04, 2026
PublishedSep 09, 2026

Abstract

Fever is among the most frequent reasons for pediatric consultation and a persistent source of caregiver anxiety. Paracetamol (acetaminophen) and ibuprofen are widely used antipyretic agents, yet rational use requires a distinction between lowering temperature and improving clinically meaningful outcomes. This narrative evidence review critically evaluates comparative efficacy, safety, combined or alternating therapy, and caregiver-related determinants of medication use. Current meta-analytic evidence indicates that ibuprofen may produce a slightly greater and longer reduction in temperature than paracetamol in some age groups; however, this pharmacodynamic advantage does not establish universal clinical superiority because evidence for improved comfort and functional outcomes is less consistent. Both agents are generally safe at recommended doses in otherwise healthy children, although ibuprofen warrants particular caution in dehydration, renal impairment, and selected infectious contexts, whereas paracetamol toxicity is strongly associated with supratherapeutic or duplicated dosing. Guidelines consistently recommend treating distress rather than the numerical temperature and do not support antipyretics for prevention of febrile seizures. Combined or alternating regimens can improve short-term defervescence but increase regimen complexity and the potential for dosing errors; therefore, routine dual-agent use is difficult to justify. The central argument of this review is that rational antipyretic therapy should be symptom-centered, individualized, and safety-oriented, with weight-based dosing and caregiver education treated as core therapeutic interventions rather than secondary advice.

Keywords

fever, children, paracetamol, acetaminophen, ibuprofen, antipyretics, rational pharmacotherapy, fever phobia.

References

1. Bertille, N., Purssell, E., Hjelm, N., Bilenko, N., Chiappini, E., de Bont, E. G. P. M., Kramer, M. S., Lepage, P., Lava, S. A. G., Mintegi, S., Sullivan, J. E., Walsh, A., Cohen, J. F., & Chalumeau, M. (2018). Symptomatic management of febrile illnesses in children: A systematic review and meta-analysis of parents’ knowledge and behaviors and their evolution over time. Frontiers in Pediatrics, 6, 279. https://doi.org/10.3389/fped.2018.00279 2. Chiappini, E., Venturini, E., Remaschi, G., Principi, N., Longhi, R., Tovo, P.-A., Becherucci, P., Bonsignori, F., Esposito, S., Festini, F., Galli, L., Lucchesi, B., Mugelli, A., Marseglia, G. L., & de Martino, M. (2017). 2016 update of the Italian Pediatric Society guidelines for management of fever in children. The Journal of Pediatrics, 180, 177–183.e1. https://doi.org/10.1016/j.jpeds.2016.09.043 3. Hay, A. D., Costelloe, C., Redmond, N. M., Montgomery, A. A., Fletcher, M., Hollinghurst, S., & Peters, T. J. (2008). Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): Randomised controlled trial. BMJ, 337, a1302. https://doi.org/10.1136/bmj.a1302 4. Misurac, J. M., Knoderer, C. A., Leiser, J. D., Nailescu, C., Wilson, A. C., & Andreoli, S. P. (2013). Nonsteroidal anti-inflammatory drugs are an important cause of acute kidney injury in children. The Journal of Pediatrics, 162(6), 1153–1159.e1. https://doi.org/10.1016/j.jpeds.2012.11.069 5. Nabulsi, M. M., Tamim, H., Mahfoud, Z., Itani, M., Sabra, R., Chamseddine, F., & Mikati, M. (2006). Alternating ibuprofen and acetaminophen in the treatment of febrile children: A pilot study. BMC Medicine, 4, Article 4. https://doi.org/10.1186/1741-7015-4-4 6. National Institute for Health and Care Excellence. (2021). Fever in under 5s: Assessment and initial management (NICE Guideline NG143). https://www.nice.org.uk/guidance/ng143 7. Niehues, T., Krafft, H., Schemmer, J., Schwarz, S., Möhler, R., & Martin, D. (2026). Clinical practice guideline: The outpatient management of fever in children and adolescents. Deutsches Ärzteblatt International, 123, 226–230. https://doi.org/10.3238/arztebl.m2026.0002 8. Perrott, D. A., Piira, T., Goodenough, B., & Champion, G. D. (2004). Efficacy and safety of acetaminophen vs ibuprofen for treating children’s pain or fever: A meta-analysis. Archives of Pediatrics & Adolescent Medicine, 158(6), 521–526. https://doi.org/10.1001/archpedi.158.6.521 9. Purssell, E., & Collin, J. (2016). Fever phobia: The impact of time and mortality—A systematic review and meta-analysis. International Journal of Nursing Studies, 56, 81–89. https://doi.org/10.1016/j.ijnurstu.2015.11.001 10. Southey, E. R., Soares-Weiser, K., & Kleijnen, J. (2009). Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever. Current Medical Research and Opinion, 25(9), 2207–2222. https://doi.org/10.1185/03007990903116255 11. Sullivan, J. E., & Farrar, H. C. (2011). Fever and antipyretic use in children. Pediatrics, 127(3), 580–587. https://doi.org/10.1542/peds.2010-3852 12. Tan, E., Braithwaite, I., McKinlay, C. J. D., & Dalziel, S. R. (2020). Comparison of acetaminophen (paracetamol) with ibuprofen for treatment of fever or pain in children younger than 2 years: A systematic review and meta-analysis. JAMA Network Open, 3(10), e2022398. https://doi.org/10.1001/jamanetworkopen.2020.22398 13. Thompson, A. P., Nesari, M., Hartling, L., & Scott, S. D. (2020). Parents’ experiences and information needs related to childhood fever: A systematic review. Patient Education and Counseling, 103(4), 750–763. https://doi.org/10.1016/j.pec.2019.10.004 14. Wong, T., Stang, A. S., Ganshorn, H., Hartling, L., Maconochie, I. K., Thomsen, A. M., & Johnson, D. W. (2013). Combined and alternating paracetamol and ibuprofen therapy for febrile children. Cochrane Database of Systematic Reviews, 2013(10), Article CD009572. https://doi.org/10.1002/14651858.CD009572.pub2 15. Ziesenitz, V. C., Zutter, A., Erb, T. O., & van den Anker, J. N. (2017). Efficacy and safety of ibuprofen in infants aged between 3 and 6 months. Paediatric Drugs, 19(4), 277–290. https://doi.org/10.1007/s40272-017-0235-3

How to Cite

Abdubannobova Dilnavoz (2026). RATIONAL USE OF ANTIPYRETICS (PARACETAMOL AND IBUPROFEN) IN THE MANAGEMENT OF FEVER IN CHILDREN: AN EVIDENCE-BASED NARRATIVE REVIEW. Science and Innovation, 5(8), 71-77. https://doi.org/10.67620/sai.58d0009